{"nct_id":"NCT04642469","title":"Phase III Study to Determine Efficacy of Durvalumab in Stage II-III Non-small Cell Lung Cancer (NSCLC) After Curative Intent Therapy.","status":"COMPLETED","status_verified_date":"2024-05","start_date":"2020-11-30","start_date_type":"ACTUAL","primary_completion_date":"2023-05-31","primary_completion_date_type":"ACTUAL","completion_date":"2024-01-15","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["AZN"]}